New 'vaccine style' treatment shows promise for slowing Parkinson's
Date
Research news
Date
Researchers at King's College London have investigated the properties of over 1,000 approved drugs to identify 2 with potential for Parkinson's.
Date
The results indicate that, when given early, the molecule Anle138b may restore dopamine levels and help slow or stop Parkinson’s in its tracks.
Date
Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.
Date
People with bipolar disorder are almost 7 times more likely to develop Parkinson's than those without the condition, according to new research published in the journal Neurology.
Date
Research shows that problems with recycling in brain cells in Parkinson's are overcome by the malaria drug clioquinol.
Date
News about joint work with the Scottish Government to research exercise and impact it has on Parkinson's.
Date
Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.
Date
Researchers have identified small molecules secreted by the skin that are maybe responsible for a unique scent in people with Parkinson's.
Date
Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.
Date
The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.